NeoChord, Inc.

NeoChord, Inc.

NeoChord, Inc.

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation.
Type
B2c
Founded
2007
Raised
$55M
Follow us
Alexa global traffic share
Latest funding Show all
$32,000,000
Venture capital (Series D) - 2019
Strategic Healthcare Investment Partners
$20,000,000
Venture capital (Series C) - 2015
Team Size
10+
Employees
$32,000,000 Venture capital (Series D)
FinSMEs

NeoChord Raises Additional $7M in Series D Financing